PVpharm
Kamila Filipiak, PhD, is currently serving as the Head of Pharmacovigilance and Clinical Safety department at PVpharm. Previous experiences include roles such as a PV Project Lead at IQVIA and a Researcher at Universidad CEU San Pablo. Kamila has a background in molecular biology and medicinal chemistry, holding a Doctor of Philosophy (PhD) in Medicinal Chemistry.
This person is not in any teams
PVpharm
www.pvpharm.com https://www.pvpharm.com/careers -PVpharm provides consultancy services in Pharmacovigilance for the Pharmaceutical Industry -We work independently or in collaboration with other PV service providers / CRO's -EU QPPV service -Local QPPV services for Spain -Training pharmacovigilance and GVP -Pharmacovigilance GVP Audits -EudraVigilance EVWeb and the XEVMPD (eXtended EudraVigilance Medicinal Product Dictionary). Possibility internal certified on-site training for pharmaceutical companies. -Registration with Eudravigilance for Pharmaceutical companies. -Introduction of information of medicinal products in the XEVMPD. -Development of IDMP implementation consultancy services. -Case management of suspected adverse reactions, including contact with reporters, MedDRA coding, Data Entry and Electronic reporting to health authorities. -Literature searches for Pharmacovigilance. -Implementation of the company's Pharmacovigilance system, including Standard Operating Procedures for Pharmacovigilance (SOPs / PNTs). -Development and revision of Pharmacovigilance documents, including Periodic Safety Update Reports (PSURs), Risk management plans (RMPs) and Elaboration of the Pharmacovigilance System Master File. JOBS: please visit our website at www.pvpharm.com